MedDataX Logo

Italian Multicenter Retrospective Observational Study on Transformed Lymphomas

NCT ID: NCT02927756

Last Updated: 2017-11-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

180 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-11-30

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study purpose is to evaluate treatment outcome and survival in patient with aggressive lymphomas transformed from Follicular Lymphoma.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-Hodgkin Lymphoma Transformed Recurrent

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Non-Hodgkin Lymphoma Transformed Recurrent Discordant Lymphomas Composite Lymphomas Follicular Lymphoma Aggressive Lymphoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Histologically confirmed transformed Follicular Lymphoma
* Age \> 18 years
* Histological transformation between January 2002 and December 2014
* Availability of data about treatment and outcome

Exclusion Criteria

* Other lymphoma diagnosis
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

A.O.U. Città della Salute e della Scienza

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Barbara Botto

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Barbara Botto, MD

Role: PRINCIPAL_INVESTIGATOR

A.O.U. Città della Salute e della Scienza

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

SC Ematologia - AOU Città della Salute e della Scienza di Torino

Torino, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Barbara Botto, MD

Role: CONTACT

Phone: +390116334553

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Barbara Botto, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FLT-Oss-2015

Identifier Type: -

Identifier Source: org_study_id